Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Peritoneal Neoplasms × Trastuzumab × Clear all

Sponsor

Conditions

Breast Neoplasms 208 Stomach Neoplasms 17 Neoplasm Metastasis 13 Breast Neoplasms, Male 13 Neoplasms 8 Esophageal Neoplasms 8 Brain Neoplasms 7 Inflammatory Breast Neoplasms 6 Colorectal Neoplasms 4 Adenocarcinoma Of Esophagus 4 Triple Negative Breast Neoplasms 3 Urologic Neoplasms 2 HER2-positive Breast Cancer 2 Gallbladder Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma, Intraductal, Noninfiltrating 2 Carcinoma, Ductal, Breast 2 Adenocarcinoma 2 Urinary Bladder Neoplasms 1 Solid Cancers 1 Rectal Neoplasms 1 Patient Preference 1 Patient Compliance 1 Osteitis Deformans 1 Neoplasm, Residual 1 Meningeal Neoplasms 1 Malignant Solid Neoplasm 1 Locally Advanced Breast Cancer 1 Lethal Congenital Contracture Syndrome 2 1 Hormone Receptor Positive Breast Cancer 1

Interventions

Paclitaxel 8 Carboplatin 6 Cisplatin 5 Hyperthermic Intraperitoneal Chemotherapy 4 Cytoreduction Surgical Procedures 3 Bevacizumab 3 nintedanib 2 Mitomycin 2 Gemcitabine 2 Fluorouracil 2 Docetaxel 2 vandetanib 1 talimogene laherparepvec 1 strattice 1 sodium thiosulfate 1 poly(I).poly(c12,U) 1 pembrolizumab 1 olaparib 1 liposomal doxorubicin 1 lentiviral minigene vaccine of COVID-19 coronavirus 1 farletuzumab 1 enzastaurin 1 catumaxomab 1 birinapant 1 atezolizumab 1 alvimopan 1 Trabectedin 1 Topotecan 1 Surgical Procedures, Operative 1 Saline Solution 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡